Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 10

Results: 13

Activation of the unliganded estrogen receptor by prolactin in breast cancer cells.

Published in:

Oncogene, 2009, v. 28, n. 10, p. 1298, doi. 10.1038/onc.2008.473

By:

González, L.;
Zambrano, A.;
Lazaro-Trueba, I.;
Lopéz, E.;
González, J. J. A.;
Martín-Pérez, J.;
Aranda, A.

Publication type:

Article

Role of miR-143 targeting KRAS in colorectal tumorigenesis.

Published in:

Oncogene, 2009, v. 28, n. 10, p. 1385, doi. 10.1038/onc.2008.474

By:

Chen, X.;
Guo, X.;
Zhang, H.;
Xiang, Y.;
Chen, J.;
Yin, Y.;
Cai, X.;
Wang, K.;
Wang, G.;
Ba, Y.;
Zhu, L.;
Wang, J.;
Yang, R.;
Zhang, Y.;
Ren, Z.;
Zen, K.;
Zhang, J.;
Zhang, C.-Y.

Publication type:

Article

Transient receptor potential channel C3 contributes to the progression of human ovarian cancer.

Published in:

Oncogene, 2009, v. 28, n. 10, p. 1320, doi. 10.1038/onc.2008.475

By:

Yang, S. L.;
Cao, Q.;
Zhou, K. C.;
Feng, Y. J.;
Wang, Y. Z.

Publication type:

Article

The cell cycle checkpoint kinase CHK2 mediates DNA damage-induced stabilization of TTK/hMps1.

Published in:

Oncogene, 2009, v. 28, n. 10, p. 1366, doi. 10.1038/onc.2008.477

By:

Yeh, Y.-H.;
Huang, Y.-F.;
Lin, T.-Y.;
Shieh, S.-Y.

Publication type:

Article

Asef2 and Neurabin2 cooperatively regulate actin cytoskeletal organization and are involved in HGF-induced cell migration.

Published in:

Oncogene, 2009, v. 28, n. 10, p. 1357, doi. 10.1038/onc.2008.478

By:

Sagara, M.;
Kawasaki, Y.;
Iemura, S.-i.;
Natsume, T.;
Takai, Y.;
Akiyama, T.

Publication type:

Article

A non-Smad mechanism of fibroblast activation by transforming growth factor-β via c-Abl and Egr-1: selective modulation by imatinib mesylate.

Published in:

Oncogene, 2009, v. 28, n. 10, p. 1285, doi. 10.1038/onc.2008.479

By:

Bhattacharyya, S.;
Ishida, W.;
Wu, M.;
Wilkes, M.;
Mori, Y.;
Hinchcliff, M.;
Leof, E.;
Varga, J.

Publication type:

Article

GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring.

Published in:

Oncogene, 2009, v. 28, n. 10, p. 1339, doi. 10.1038/onc.2008.480

By:

Sun, P.;
Nallar, S. C.;
Kalakonda, S.;
Lindner, D. J.;
Martin, S. S.;
Kalvakolanu, D. V.

Publication type:

Article

Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms.

Published in:

Oncogene, 2009, v. 28, n. 10, p. 1309, doi. 10.1038/onc.2008.481

By:

Hollmén, M.;
Määttä, J. A.;
Bald, L.;
Sliwkowski, M. X.;
Elenius, K.

Publication type:

Article

The Tcl1 oncogene defines secondary hair germ cells differentiation at catagen–telogen transition and affects stem-cell marker CD34 expression.

Published in:

Oncogene, 2009, v. 28, n. 10, p. 1329, doi. 10.1038/onc.2008.489

By:

Ragone, G.;
Bresin, A.;
Piermarini, F.;
Lazzeri, C.;
Picchio, M. C.;
Remotti, D.;
Kang, S.-M.;
Cooper, M. D.;
Croce, C. M.;
Narducci, M. G.;
Russo, G.

Publication type:

Article

The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras.

Published in:

Oncogene, 2009, v. 28, n. 10, p. 1393, doi. 10.1038/onc.2008.491

By:

Ho, V. M.;
Schaffer, B. E.;
Karnezis, A. N.;
Park, K. S.;
Sage, J.

Publication type:

Article

The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells.

Published in:

Oncogene, 2009, v. 28, n. 10, p. 1348, doi. 10.1038/onc.2008.493

By:

Zhou, Q.;
Geahlen, R. L.

Publication type:

Article

Runx3 expression in gastrointestinal tract epithelium: resolving the controversy.

Published in:

Oncogene, 2009, v. 28, n. 10, p. 1379, doi. 10.1038/onc.2008.496

By:

Ito, K.;
Inoue, K.-i.;
Bae, S.-C.;
Ito, Y.

Publication type:

Article

Lack of p53 induction in fish cells by model chemotherapeutics.

Published in:

2009

By:

Rau Embry, M.;
Billiard, S. M.;
Di Giulio, R. T.

Publication type:

Correction Notice